APA aipamena

Ren, B., Wang, W., Shen, J., Li, W., Ni, C., & Zhu, X. (2019). Transarterial Chemoembolization (TACE) Combined with Sorafenib versus TACE Alone for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Study. J Cancer.

Chicago Style aipamena

Ren, Baosheng, Wansheng Wang, Jian Shen, Wanci Li, Caifang Ni, and Xiaoli Zhu. "Transarterial Chemoembolization (TACE) Combined With Sorafenib Versus TACE Alone for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Study." J Cancer 2019.

MLA aipamena

Ren, Baosheng, et al. "Transarterial Chemoembolization (TACE) Combined With Sorafenib Versus TACE Alone for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Study." J Cancer 2019.